Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR‐138‐5p and activation of AKT/mTOR signaling pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR‐138‐5p and activation of AKT/mTOR signaling pathway
Authors
Keywords
-
Journal
Pharmacology Research & Perspectives
Volume 9, Issue 1, Pages -
Publisher
Wiley
Online
2021-02-11
DOI
10.1002/prp2.720
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?
- (2019) Giandomenico Roviello et al. INVESTIGATIONAL NEW DRUGS
- The prognostic value and mechanisms of lncRNA UCA1 in human cancer
- (2019) Fei Yao et al. Cancer Management and Research
- LncRNA UCA1 promotes gefitinib resistance as a ceRNA to target FOSL2 by sponging miR-143 in non-small cell lung cancer
- (2019) Xiliu Chen et al. Molecular Therapy-Nucleic Acids
- UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis
- (2018) Junrong Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma
- (2018) Xue-Mei Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Noncoding RNAs in liver cancer stem cells: The big impact of little things
- (2018) Hongwei Lv et al. CANCER LETTERS
- Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
- (2018) Liang Chang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
- (2018) Hai Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
- (2018) Ádám Nagy et al. Scientific Reports
- Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma
- (2018) Xin Wang et al. Journal of Cancer
- Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
- (2018) Jian Zhou et al. Liver Cancer
- LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer
- (2018) Lin Wang et al. BIOSCIENCE REPORTS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141
- (2018) Lili Wu et al. Cell Communication and Signaling
- Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression
- (2017) Ji-Nan Xiao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
- (2016) Le Qu et al. CANCER CELL
- The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells
- (2016) Xu Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy
- (2016) Ling Zhang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer
- (2016) Chao Shang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells
- (2016) Jingjing Pan et al. CANCER LETTERS
- Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma
- (2016) Guihui Qin et al. CANCER LETTERS
- FOLFOX4 or sorafenib as the first-line treatments for advanced hepatocellular carcinoma: A cost-effectiveness analysis
- (2016) Pengfei Zhang et al. DIGESTIVE AND LIVER DISEASE
- Different expression of VEGF and EGFL7 in human hepatocellular carcinoma
- (2016) Luisa Campagnolo et al. DIGESTIVE AND LIVER DISEASE
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma
- (2016) Peng Du et al. Oncotarget
- Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway
- (2016) Chihua Wu et al. MEDICAL SCIENCE MONITOR
- LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p
- (2016) Zehua Bian et al. Scientific Reports
- A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner
- (2015) Jian-Hong Fang et al. HEPATOLOGY
- Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
- (2015) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
- (2015) Joseph George et al. SEMINARS IN LIVER DISEASE
- Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT
- (2015) J Yang et al. Cell Death & Disease
- Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer
- (2015) Ningning Cheng et al. Oncotarget
- Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway
- (2015) Feng Wang et al. Oncotarget
- Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
- (2015) Guangchao Cao et al. MEDICAL SCIENCE MONITOR
- Rapamycin: One Drug, Many Effects
- (2014) Jing Li et al. Cell Metabolism
- Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
- (2014) Yu Fan et al. FEBS Journal
- Oxaliplatin/5-fluorouracil in advanced hepatocellular carcinoma: case report and single-center retrospective review
- (2014) Robert Goldstein et al. Future Oncology
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization and Resistance Mechanisms of A 5-fluorouracil-resistant Hepatocellular Carcinoma Cell Line
- (2013) Wei Gu et al. Asian Pacific Journal of Cancer Prevention
- Long noncoding RNAs: Novel insights into hepatocelluar carcinoma
- (2013) Yong He et al. CANCER LETTERS
- Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma
- (2013) Wenling Zhang et al. JOURNAL OF MOLECULAR HISTOLOGY
- Inhibition of rapamycin-induced Akt phosphorylation by cotylenin A correlates with their synergistic growth inhibition of cancer cells
- (2012) TAKASHI KASUKABE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines
- (2012) Zhen Liu et al. Chinese Journal of Cancer
- Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation
- (2011) Zhe Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation
- (2011) Ming-chun Lai et al. MEDICAL ONCOLOGY
- The functional role of long non-coding RNA in human carcinomas
- (2011) Ewan A Gibb et al. Molecular Cancer
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started